So there, there are mass of drug is Philip Hemme: also, Fredrik Tiberg: yeah
These are also the doses studied and approved for prevention of secondary cardiovascular events and metabolic dysfunction-associated steatotic liver disease (semaglutide) and for sleep apnea (tirzepatide)
New in Diabetes Drugs: Healthier Hearts, Improved Glucose Management Research presented at ADAs 2017 conference shows exciting advances in a host of diabetes drugs including heart benefits, improved glucose control, lower cholesterol, weight loss, less hypoglycemia, and more FDA Advisory Panel Recommends Semaglutide for Approval Novo Nordisks once-weekly injectable GLP-1 for type 2 diabetes recommended for approval, given strong A1c reduction and weight loss
It enhances insulin secretion, suppresses glucagon release, and slows the release of contents from the stomach
I dont always hit that number, but I try
Find everything you need to know about GLP-1 drugs-all in one place